Fabrazyme.com

Visit fabrazyme.com
  • 1 year ago

    Last scanned

  • 24 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Fabrazyme.com

Visit fabrazyme.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

Fabrazyme® (agalsidase beta) | ERT for Fabry Disease

Fabrazyme is an enzyme replacement therapy (ERT) used to treat patients with Fabry disease for over 17 years. See how it works, get copay assistance for qualified patients and more.

Fabrazyme.com thumbnail
Fabrazyme.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for fabrazyme.com: 18.67.65.18, 18.67.65.34, 18.67.65.52, 18.67.65.89. Moreover, DNS used with this website include ns1.sanofi-synthelabo.com, ns2.sanofi-synthelabo.com, ns3.sanofi-synthelabo.com, ns4.sanofi-synthelabo.com. Subnet identifier ranges from 18.64.0.0 to 18.67.255.255. Classless Inter-Domain Routing (CIDR) is 18.64.0.0/14. ARIN net type is Reallocated.

  • 1 year ago

    Last scanned

  • 24 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

Domain & Keywords

The registrar of fabrazyme.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2024-12-06. According to open source data, you can reach the owner at domain.names@sanofi.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.

  • Fabry disease
  • Fabrazyme
  • fabry disease treatment centers
  • fabrazyme package insert
  • agalsidase beta

Websites similar to fabrazyme.com